Immeasurable time bias in observational studies of drug effects on mortality.
暂无分享,去创建一个
[1] J. Maurer. Inhaled Corticosteroids and Mortality in COPD , 2008 .
[2] Robert H Lyles,et al. Inference for case-control studies when exposure status is both informatively missing and misclassified. , 2006, Statistics in medicine.
[3] M. Etminan,et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. , 2006, Journal of the American College of Cardiology.
[4] Ping Li,et al. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis , 2006, The Lancet.
[5] J. Hippisley-Cox,et al. Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case–control analysis , 2005, Heart.
[6] N. Pride,et al. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. , 2005, American journal of respiratory and critical care medicine.
[7] J. Hippisley-Cox,et al. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis , 2005, BMJ : British Medical Journal.
[8] J. Tu,et al. Statin use and survival outcomes in elderly patients with heart failure. , 2005, Archives of internal medicine.
[9] A. Laupacis,et al. Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community , 2004, Journal of General Internal Medicine.
[10] R. Gray,et al. Comparison of the missing-indicator method and conditional logistic regression in 1:m matched case-control studies with missing exposure values. , 2004, American journal of epidemiology.
[11] Kenneth Rice. Full-likelihood approaches to misclassification of a binary exposure in matched case-control studies. , 2003, Statistics in medicine.
[12] J. Bourbeau,et al. Inhaled corticosteroids and hospitalisation due to exacerbation of COPD , 2003, European Respiratory Journal.
[13] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[14] A M Epstein,et al. The outcomes movement--will it get us where we want to go? , 1990, The New England journal of medicine.
[15] J. Schlesselman,et al. Exposure opportunity in epidemiologic studies. , 1987, American journal of epidemiology.
[16] C. Poole. Exposure opportunity in case-control studies. , 1986, American journal of epidemiology.
[17] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .